Responses
E-Poster viewings
Ovarian Cancer
IGCS19-0379
317 Feasibility of an outpatient 12-step desensitization for patients with history of carboplatin hypersensitivity reactions (HSR) undergoing retreatment with carboplatin for recurrent ovarian or endometrial cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.